Inventor
Qi-Qi Feng
Inventor
Beijing, CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds13%
C12NMicroorganisms or enzymes7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture7%
C12YEnzymes7%
PatentTitleYear
11,053,317Pharmaceutical preparation stably comprising CD147 monoclonal antibody202110,351,594Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging20199,969,995Methods for recombinant expression of beta-glucosidase gene20189,890,193'Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof'2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2019Patents assigned to SHANGHAI LUMOSA THERAPEUTICS CO LTD (2)· patent assignee history
2018Patents assigned to WILMAR SHANGHAI BIOTECHNOLOGY RES & DEV CT CO LTD (1)· patent assignee history
2018–2019Based in Beijing, CN· patent location history
2018Based in Shanghai, CN· patent location history
2021Patents assigned to JIANGSU PACIFIC MEINUOKE BIO PHARMACEUTICAL CO LTD (1)· patent assignee history
2021Based in Changzhou, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHANGHAI LUMOSA THERAPEUTICS CO LTD | 2 | 2018–2019 |
| JIANGSU PACIFIC MEINUOKE BIO PHARMACEUTICAL CO LTD | 1 | 2021 |
| WILMAR SHANGHAI BIOTECHNOLOGY RES & DEV CT CO LTD | 1 | 2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Beijing, CN | 2 | 2018–2019 |
| Changzhou, CN | 1 | 2021 |
| Shanghai, CN | 1 | 2018 |